Choate Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,889
| Closed | -$1.16M | – | 410 |
|
|
2023
Q4 | $1.16M | Sell |
4,889
-278
| -5% | -$65.7K | 0.04% | 164 |
|
|
2023
Q3 | $1.01M | Buy |
5,167
+58
| +1% | +$11.4K | 0.04% | 159 |
|
|
2023
Q2 | $1.07M | Sell |
5,109
-2,711
| -35% | -$570K | 0.04% | 136 |
|
|
2023
Q1 | $1.58M | Buy |
7,820
+1,200
| +18% | +$242K | 0.08% | 100 |
|
|
2022
Q4 | $1.44M | Buy |
6,620
+4,458
| +206% | +$971K | 0.09% | 98 |
|
|
2022
Q3 | $425K | Buy |
2,162
+636
| +42% | +$125K | 0.03% | 172 |
|
|
2022
Q2 | $327K | Buy |
1,526
+328
| +27% | +$70.3K | 0.02% | 206 |
|
|
2022
Q1 | $340K | Buy |
+1,198
| New | +$340K | 0.02% | 232 |
|